Logo image of WELL-DB.CA

WELL HEALTH TECHNOLOGIES (WELL-DB.CA) Stock Fundamental Analysis

TSX:WELL-DB - Toronto Stock Exchange - CA94947LAC69 - Currency: CAD

100.5  0 (0%)

Fundamental Rating

5

Overall WELL-DB gets a fundamental rating of 5 out of 10. We evaluated WELL-DB against 17 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of WELL-DB get a neutral evaluation. Nothing too spectacular is happening here. WELL-DB is valued quite expensively, but it does show have an excellent growth rating. These ratings could make WELL-DB a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

WELL-DB had positive earnings in the past year.
In the past year WELL-DB had a positive cash flow from operations.
In multiple years WELL-DB reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: WELL-DB reported negative operating cash flow in multiple years.
WELL-DB.CA Yearly Net Income VS EBIT VS OCF VS FCFWELL-DB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

1.2 Ratios

The Return On Assets of WELL-DB (4.61%) is better than 75.00% of its industry peers.
With a decent Return On Equity value of 8.67%, WELL-DB is doing good in the industry, outperforming 75.00% of the companies in the same industry.
WELL-DB's Return On Invested Capital of 2.80% is fine compared to the rest of the industry. WELL-DB outperforms 62.50% of its industry peers.
Industry RankSector Rank
ROA 4.61%
ROE 8.67%
ROIC 2.8%
ROA(3y)-1.11%
ROA(5y)-3.61%
ROE(3y)-2.32%
ROE(5y)-6.61%
ROIC(3y)N/A
ROIC(5y)N/A
WELL-DB.CA Yearly ROA, ROE, ROICWELL-DB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 -1K

1.3 Margins

The Profit Margin of WELL-DB (7.67%) is better than 87.50% of its industry peers.
WELL-DB has a better Operating Margin (4.50%) than 62.50% of its industry peers.
Looking at the Gross Margin, with a value of 44.16%, WELL-DB is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of WELL-DB has grown nicely.
Industry RankSector Rank
OM 4.5%
PM (TTM) 7.67%
GM 44.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.34%
GM growth 5Y10.4%
WELL-DB.CA Yearly Profit, Operating, Gross MarginsWELL-DB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), WELL-DB is destroying value.
WELL-DB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, WELL-DB has more shares outstanding
WELL-DB has a worse debt/assets ratio than last year.
WELL-DB.CA Yearly Shares OutstandingWELL-DB.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
WELL-DB.CA Yearly Total Debt VS Total AssetsWELL-DB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

2.2 Solvency

An Altman-Z score of 20.90 indicates that WELL-DB is not in any danger for bankruptcy at the moment.
The Altman-Z score of WELL-DB (20.90) is better than 93.75% of its industry peers.
The Debt to FCF ratio of WELL-DB is 3.48, which is a good value as it means it would take WELL-DB, 3.48 years of fcf income to pay off all of its debts.
WELL-DB has a Debt to FCF ratio of 3.48. This is in the better half of the industry: WELL-DB outperforms 68.75% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that WELL-DB is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.44, WELL-DB is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.48
Altman-Z 20.9
ROIC/WACC0.35
WACC7.88%
WELL-DB.CA Yearly LT Debt VS Equity VS FCFWELL-DB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.14 indicates that WELL-DB should not have too much problems paying its short term obligations.
WELL-DB has a better Current ratio (1.14) than 62.50% of its industry peers.
WELL-DB has a Quick Ratio of 1.13. This is a normal value and indicates that WELL-DB is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.13, WELL-DB is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.13
WELL-DB.CA Yearly Current Assets VS Current LiabilitesWELL-DB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 500.00% over the past year.
Looking at the last year, WELL-DB shows a very strong growth in Revenue. The Revenue has grown by 36.56%.
The Revenue has been growing by 136.00% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1000%
Revenue 1Y (TTM)36.56%
Revenue growth 3Y149.11%
Revenue growth 5Y136%
Sales Q2Q%23.12%

3.2 Future

The Earnings Per Share is expected to grow by 37.69% on average over the next years. This is a very strong growth
Based on estimates for the next years, WELL-DB will show a quite strong growth in Revenue. The Revenue will grow by 14.31% on average per year.
EPS Next Y212.7%
EPS Next 2Y70.12%
EPS Next 3Y47.56%
EPS Next 5Y37.69%
Revenue Next Year29.47%
Revenue Next 2Y22.74%
Revenue Next 3Y17.52%
Revenue Next 5Y14.31%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
WELL-DB.CA Yearly Revenue VS EstimatesWELL-DB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
WELL-DB.CA Yearly EPS VS EstimatesWELL-DB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 837.50, WELL-DB can be considered very expensive at the moment.
WELL-DB's Price/Earnings ratio is a bit cheaper when compared to the industry. WELL-DB is cheaper than 62.50% of the companies in the same industry.
When comparing the Price/Earnings ratio of WELL-DB to the average of the S&P500 Index (29.62), we can say WELL-DB is valued expensively.
Based on the Price/Forward Earnings ratio of 624.47, the valuation of WELL-DB can be described as expensive.
WELL-DB's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, WELL-DB is valued quite expensively.
Industry RankSector Rank
PE 837.5
Fwd PE 624.47
WELL-DB.CA Price Earnings VS Forward Price EarningsWELL-DB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600 800

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WELL-DB indicates a slightly more expensive valuation: WELL-DB is more expensive than 62.50% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of WELL-DB indicates a slightly more expensive valuation: WELL-DB is more expensive than 62.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 220.45
EV/EBITDA 228.79
WELL-DB.CA Per share dataWELL-DB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates WELL-DB does not grow enough to justify the current Price/Earnings ratio.
WELL-DB's earnings are expected to grow with 47.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.94
PEG (5Y)N/A
EPS Next 2Y70.12%
EPS Next 3Y47.56%

More info and screens

0

5. Dividend

5.1 Amount

WELL-DB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WELL HEALTH TECHNOLOGIES

TSX:WELL-DB (2/21/2025, 7:00:00 PM)

100.5

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)03-19 2025-03-19/amc
Inst Owners6.33%
Inst Owner ChangeN/A
Ins Owners8.41%
Ins Owner ChangeN/A
Market Cap25.12B
Analysts81
Price Target145.96 (45.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8921.57%
Min EPS beat(2)-3335.29%
Max EPS beat(2)21178.4%
EPS beat(4)2
Avg EPS beat(4)4048.19%
Min EPS beat(4)-3335.29%
Max EPS beat(4)21178.4%
EPS beat(8)3
Avg EPS beat(8)1725.39%
EPS beat(12)3
Avg EPS beat(12)1063.25%
EPS beat(16)4
Avg EPS beat(16)719.15%
Revenue beat(2)1
Avg Revenue beat(2)0.18%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)0.74%
Revenue beat(4)2
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)3.49%
Revenue beat(8)4
Avg Revenue beat(8)0.9%
Revenue beat(12)8
Avg Revenue beat(12)1.53%
Revenue beat(16)11
Avg Revenue beat(16)2.07%
PT rev (1m)17.65%
PT rev (3m)-9.74%
EPS NQ rev (1m)62.08%
EPS NQ rev (3m)62.08%
EPS NY rev (1m)-13.53%
EPS NY rev (3m)-58.78%
Revenue NQ rev (1m)0.33%
Revenue NQ rev (3m)0.35%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 837.5
Fwd PE 624.47
P/S 26.23
P/FCF 220.45
P/OCF 199.17
P/B 29.65
P/tB N/A
EV/EBITDA 228.79
EPS(TTM)0.12
EY0.12%
EPS(NY)0.16
Fwd EY0.16%
FCF(TTM)0.46
FCFY0.45%
OCF(TTM)0.5
OCFY0.5%
SpS3.83
BVpS3.39
TBVpS-0.81
PEG (NY)3.94
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.61%
ROE 8.67%
ROCE 3.28%
ROIC 2.8%
ROICexc 2.94%
ROICexgc 18.37%
OM 4.5%
PM (TTM) 7.67%
GM 44.16%
FCFM 11.9%
ROA(3y)-1.11%
ROA(5y)-3.61%
ROE(3y)-2.32%
ROE(5y)-6.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.34%
GM growth 5Y10.4%
F-Score6
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.48
Debt/EBITDA 3.34
Cap/Depr 17.87%
Cap/Sales 1.27%
Interest Coverage 1.62
Cash Conversion 113.38%
Profit Quality 155.17%
Current Ratio 1.14
Quick Ratio 1.13
Altman-Z 20.9
F-Score6
WACC7.88%
ROIC/WACC0.35
Cap/Depr(3y)10.65%
Cap/Depr(5y)16.03%
Cap/Sales(3y)1.02%
Cap/Sales(5y)1.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1000%
EPS Next Y212.7%
EPS Next 2Y70.12%
EPS Next 3Y47.56%
EPS Next 5Y37.69%
Revenue 1Y (TTM)36.56%
Revenue growth 3Y149.11%
Revenue growth 5Y136%
Sales Q2Q%23.12%
Revenue Next Year29.47%
Revenue Next 2Y22.74%
Revenue Next 3Y17.52%
Revenue Next 5Y14.31%
EBIT growth 1Y56.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year264.45%
EBIT Next 3Y69.86%
EBIT Next 5Y44.52%
FCF growth 1Y130.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y125.39%
OCF growth 3YN/A
OCF growth 5YN/A